These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25451399)

  • 1. Bioprofiling of platelets in medicated patients with depression.
    Hüfner K; Kandler C; Koudouovoh-Tripp P; Egeter J; Hochstrasser T; Stemer B; Malik P; Giesinger J; Humpel C; Sperner-Unterweger B
    J Affect Disord; 2015 Feb; 172():81-8. PubMed ID: 25451399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs.
    Bismuth-Evenzal Y; Gonopolsky Y; Gurwitz D; Iancu I; Weizman A; Rehavi M
    J Affect Disord; 2012 Jan; 136(1-2):99-103. PubMed ID: 21893349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial.
    Jain N; Wan F; Kothari M; Adelodun A; Ware J; Sarode R; Hedayati SS
    BMC Nephrol; 2019 Oct; 20(1):395. PubMed ID: 31664940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortisol, platelet serotonin content, and platelet activity in patients with major depression and type 2 diabetes: an exploratory investigation.
    Zahn D; Petrak F; Franke L; Hägele AK; Juckel G; Lederbogen F; Neubauer H; Norra C; Uhl I; Herpertz S
    Psychosom Med; 2015; 77(2):145-55. PubMed ID: 25626989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombotic platelet phenotype in major depression: downregulation by antidepressant treatment.
    Lopez-Vilchez I; Serra-Millas M; Navarro V; Rosa Hernandez M; Villalta J; Diaz-Ricart M; Gasto C; Escolar G; Galan AM
    J Affect Disord; 2014 Apr; 159():39-45. PubMed ID: 24679387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newly diagnosed depression is associated with increased beta-thromboglobulin levels and increased expression of platelet activation markers and platelet derived CD40-CD40L.
    Neubauer H; Petrak F; Zahn D; Pepinghege F; Hägele AK; Pirkl PA; Uhl I; Juckel G; Mügge A; Herpertz S
    J Psychiatr Res; 2013 Jul; 47(7):865-71. PubMed ID: 23583028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy.
    Leo R; Di Lorenzo G; Tesauro M; Razzini C; Forleo GB; Chiricolo G; Cola C; Zanasi M; Troisi A; Siracusano A; Lauro R; Romeo F
    J Clin Psychiatry; 2006 Nov; 67(11):1760-6. PubMed ID: 17196057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet reactivity in depressed patients treated with paroxetine: preliminary findings.
    Musselman DL; Marzec UM; Manatunga A; Penna S; Reemsnyder A; Knight BT; Baron A; Hanson SR; Nemeroff CB
    Arch Gen Psychiatry; 2000 Sep; 57(9):875-82. PubMed ID: 10986551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet serotonin and serotonin transporter as peripheral surrogates in depression and anxiety patients.
    Zhuang X; Xu H; Fang Z; Xu C; Xue C; Hong X
    Eur J Pharmacol; 2018 Sep; 834():213-220. PubMed ID: 30031795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet 5-HT(1A) receptor correlates with major depressive disorder in drug-free patients.
    Zhang ZJ; Wang D; Man SC; Ng R; McAlonan GM; Wong HK; Wong W; Lee J; Tan QR
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():74-9. PubMed ID: 24657886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study.
    van Zyl LT; Lespérance F; Frasure-Smith N; Malinin AI; Atar D; Laliberté MA; Serebruany VL
    J Thromb Thrombolysis; 2009 Jan; 27(1):48-56. PubMed ID: 18188512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced platelet G protein-coupled receptor kinase 2 in major depressive disorder: antidepressant treatment-induced upregulation of GRK2 protein discriminates between responder and non-responder patients.
    García-Sevilla JA; Alvaro-Bartolomé M; Díez-Alarcia R; Ramos-Miguel A; Puigdemont D; Pérez V; Alvarez E; Meana JJ
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):721-30. PubMed ID: 20493668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential changes in platelet reactivity induced by acute physical compared to persistent mental stress.
    Hüfner K; Koudouovoh-Tripp P; Kandler C; Hochstrasser T; Malik P; Giesinger J; Semenitz B; Humpel C; Sperner-Unterweger B
    Physiol Behav; 2015 Nov; 151():284-91. PubMed ID: 26192713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet 5-HT2A-receptor-mediated induction of aggregation is not altered in major depression.
    Gómez-Gil E; Gastó C; Díaz-Ricart M; Carretero M; Salamero M; Catalán R; Escolar G
    Hum Psychopharmacol; 2002 Dec; 17(8):419-24. PubMed ID: 12457378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased coronary events in depressed cardiovascular patients: 5-HT2A receptor as missing link?
    Schins A; Honig A; Crijns H; Baur L; Hamulyák K
    Psychosom Med; 2003; 65(5):729-37. PubMed ID: 14508013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitors and endothelial function in women.
    Hantsoo L; Czarkowski KA; Child J; Howes C; Epperson CN
    J Womens Health (Larchmt); 2014 Jul; 23(7):613-8. PubMed ID: 24886268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of subsyndromal residual symptoms after remission of major depression in patients without cardiovascular disease may condition maintenance of elevated platelet factor 4 and β-thromboglobulin plasma levels.
    Delle Chiaie R; Capra E; Salviati M; Trabucchi G; Pancheri C; Corrado A; Biondi M
    J Affect Disord; 2013 Sep; 150(2):664-7. PubMed ID: 23611535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, longitudinal study of platelet serotonin and plasma brain-derived neurotrophic factor concentrations in major depression: effects of vortioxetine treatment.
    Sagud M; Nikolac Perkovic M; Vuksan-Cusa B; Maravic A; Svob Strac D; Mihaljevic Peles A; Zivkovic M; Kusevic Z; Pivac N
    Psychopharmacology (Berl); 2016 Sep; 233(17):3259-67. PubMed ID: 27356518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression. Grupo de Trastornos Afectivos.
    Figueras G; Pérez V; San Martino O; Alvarez E; Artigas F
    Biol Psychiatry; 1999 Aug; 46(4):518-24. PubMed ID: 10459402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.
    Alvarez JC; Gluck N; Arnulf I; Quintin P; Leboyer M; Pecquery R; Launay JM; Perez-Diaz F; Spreux-Varoquaux O
    Clin Pharmacol Ther; 1999 Dec; 66(6):617-24. PubMed ID: 10613618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.